Novartis' Tekturna, diuretic combo wins FDA approval

01/21/2008 | Wall Street Journal (free content), The

The FDA has granted Novartis AG approval to market a combination of its blood-pressure lowering drug Tekturna and the diuretic HCT in a single-tablet formulation, the company announced Monday. The combination drug proved more effective in lowering blood pressure than either component alone in clinical trials.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations